Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients

scientific article published on August 2015

Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/1755-5922.12126
P698PubMed publication ID25903419
P5875ResearchGate publication ID275359894

P50authorAlice Cristina RodriguesQ42534175
Alvaro CerdaQ87736878
P2093author name stringMario Hiroyuki Hirata
Rosario Dominguez Crespo Hirata
Cristina Moreno Fajardo
Egidio Lima Dorea
Fabiana Dalla Vecchia Genvigir
Camila Alves
Gelba Almeida Pinto
Maria Cecilia Gusukuma
P2860cites workInfluence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expressionQ42487088
Monocyte expression of adhesion molecules during low- and high-flux polysulfone hemodialysis and the effect of atorvastatin administrationQ43196119
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.Q44342175
Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatin.Q46174137
High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study.Q46938424
Ezetimib influences the expression of raft-associated antigens in human monocytesQ46945579
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Getting to the site of inflammation: the leukocyte adhesion cascade updatedQ29547271
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsQ29547856
Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44Q30582616
SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI StudyQ33614699
Effectiveness of Ezetimibe in Reducing the Estimated Risk for Fatal Cardiovascular Events in Hypercholesterolaemic Patients with Inadequate Lipid Control While on Statin Monotherapy as Measured by the SCORE ModelQ35203211
Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Q36088110
Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibeQ36686462
Ezetimibe: cholesterol lowering and beyondQ37134467
Pleiotropic effects of statins. - Basic research and clinical perspectives -.Q37252114
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseasesQ37307308
P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall.Q37612342
Inflammation in atherosclerosis: transition from theory to practiceQ37672113
Atherosclerosis: current pathogenesis and therapeutic optionsQ37953777
Effect of high-dose statin versus low-dose statin plus ezetimibe on endothelial function: a meta-analysis of randomized trials.Q38019682
Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effectQ39883050
P433issue4
P921main subjecthypercholesterolemiaQ762713
P304page(s)168-176
P577publication date2015-08-01
P1433published inCardiovascular TherapeuticsQ1871490
P1476titleModulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients
P478volume33

Reverse relations

cites work (P2860)
Q47907093Cardiovascular profile improvement during Natalizumab treatment
Q48302242Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients.
Q46292627Nonhuman Primates and Translational Research-Cardiovascular Disease.

Search more.